Gliaid MV 2.3 Tablet ER
Manufacturer
Workcell Solutions Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Key Information
Short Description
Gliaid MV 2.3 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet ER
Introduction
Gliaid MV 2.3 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gliaid MV 2.3 Tablet ER is to be taken empty stomach.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Gliaid MV 2.3 Tablet ER.
Breastfeeding Warning
Gliaid MV 2.3 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning
Gliaid MV 2.3 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Gliaid MV 2.3 Tablet ER is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Trivolib Forte 2 Tablet
Voglital GM 0.3 Tablet
Vogloyd 3D 2.3 Tablet ER
Voglitum-Trio 0.3 Tablet ER
Qtoglym 0.3/2 Tablet ER
Glimzab MV 2mg/500mg/0.3mg Tablet ER
Switglim MV 2/0.3 Tablet ER
Voglimend-GM 3 SR Tablet
Glipament MV 2 Tablet ER
Glycilarc Trio 2/0.3mg Tablet ER
Frequently asked questions
What is Gliaid MV 2.3 Tablet ER?
Gliaid MV 2.3 Tablet ER is a combination of Glimepiride, Metformin, and Voglibose used to treat type 2 diabetes mellitus (DM). It improves blood glucose levels when taken with proper diet and exercise.
What are the possible side effects of Gliaid MV 2.3 Tablet ER?
Common side effects include hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Are there any specific conditions in which Gliaid MV 2.3 Tablet ER should not be taken?
Avoid using this medicine if you are allergic to its components or excipients. It's also avoided for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Gliaid MV 2.3 Tablet ER?
No, Gliaid MV 2.3 Tablet ER should not be taken with alcohol because it can lower blood sugar levels and increase the risk of lactic acidosis.
Can the use of Gliaid MV 2.3 Tablet ER cause hypoglycemia?
Yes, Gliaid MV 2.3 Tablet ER may cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to happen if you miss meals, drink alcohol, over-exercise, or take other diabetes medications.
What are the instructions for storage and disposal of Gliaid MV 2.3 Tablet ER?
Store in original packaging, tightly closed. Follow the instructions on the pack label. Discard unused medication. Do not give to pets or children.
